CreditReports.dk
HomeScreen companies

XGX Pharma ApS Financials, key figures and credit report

CVR number: 32289290 Established 2009 Industry: 46 Wholesale trade
Company contact details
Frederiksgade 11, 1265 København K msa@vitalpharmanordic.com tel: 70276627
Gross profit 32 338.4 kDKK FY 2025 +101.7% vs 2024
EBIT 21 199.2 kDKK FY 2025 +224.3% vs 2024
Net debt 5 119.0 kDKK FY 2025 -19.1% vs 2024
Quick ratio 1.4 FY 2025 +0.1 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit14 515.292 917.688 100.8216 033.7932 338.38
Employee benefit expenses-5 008.32-4 419.96-5 200.47-7 262.73-8 149.18
Total depreciation- 434.13- 787.67-1 424.09-2 234.34-2 990.05
EBIT9 072.84-2 289.951 476.266 536.7321 199.15
Other financial income5.790.587.7034.53
Other financial expenses- 407.80- 484.94- 786.35- 873.21- 870.31
Net income from associates (fin.)143.1387.85-82.30-50.52139.82
Pre-tax profit8 931.62-2 681.26623.695 673.0820 508.85
Income taxes-1 683.12838.70- 162.79-1 219.65-4 434.73
Net earnings7 248.51-1 842.55460.894 453.4316 074.12

Assets (kDKK)

2021
2022
2023
2024
2025
Development expenditure11 329.4714 835.8416 329.0917 499.1018 371.09
Intangible rights649.94668.50769.22
Intangible assets total11 329.4714 835.8416 979.0318 167.6019 140.31
Machinery and equipment527.16365.02170.6322.7413.84
Tangible assets total527.16365.02170.6322.7413.84
Holdings in group member companies143.13230.98148.69105.50245.32
Investments total334.61437.94381.67341.70486.09
Long term receivables total
Finished products/goods2 395.163 044.192 679.143 266.206 284.51
Inventories total2 395.163 044.192 679.143 266.206 284.51
Current trade debtors2 589.393 968.112 932.7613 053.8210 682.42
Current amounts owed by group member comp.250.00164.70288.25559.30
Current other receivables3 627.184 508.676 144.473 736.8917 948.43
Current deferred tax assets204.44479.90148.80129.00
Short term receivables total6 671.028 956.689 390.7317 207.9629 190.14
Balance sheet total (assets)21 257.4127 639.6829 601.2039 006.2055 114.89

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital132.98400.00400.00400.00400.00
Shares repurchased4 000.00
Other reserves9 039.0811 819.7412 885.3813 747.4614 567.43
Retained earnings-3 251.703 421.55513.36-3 887.83- 254.37
Profit of the financial year7 248.51-1 842.55460.894 453.4316 074.12
Shareholders equity total13 168.8713 798.7414 259.6318 713.0630 787.18
Provisions2 508.611 669.911 832.713 052.364 016.38
Non-current loans from credit institutions1 947.947 648.625 873.363 952.76
Non-current liabilities total1 947.947 648.625 873.363 952.76
Current loans from credit institutions0.061 775.262 370.73
Advances received752.55
Current trade creditors2 343.633 309.294 644.414 790.24
Current owed to participating1.93
Current owed to group member55.815 119.01
Short-term deferred tax liabilities611.603 489.10
Other non-interest bearing current liabilities3 020.331 370.422 550.966 270.956 912.98
Current liabilities total3 631.994 522.417 635.5113 288.0220 311.32
Balance sheet total (liabilities)21 257.4127 639.6829 601.2039 006.2055 114.89
Page generated